Completed PHASE1 INTERVENTIONAL 4-arm NCT04903314

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

A Phase I, Open-Label, Pharmacokinetic, Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Sponsor: SK Life Science, Inc.

Conditions Partial Epilepsy

Interventions Xcopri

Updated 25 times since 2021 Last updated: Feb 27, 2026 Started: May 27, 2021 Primary completion: Nov 6, 2025 Completion: Nov 6, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Partial Epilepsy and is currently completed. SK Life Science, Inc. leads this study, which shows 25 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

25 versions recorded

Mar 2026 — Present [monthly]

Completed PHASE1

Status: Recruiting → Completed
Oct 2025 — Mar 2026 [monthly]

Recruiting PHASE1
Sep 2025 — Oct 2025 [monthly]

Recruiting PHASE1
Jun 2025 — Sep 2025 [monthly]

Recruiting PHASE1
Apr 2025 — Jun 2025 [monthly]

Recruiting PHASE1

▶ Show 20 earlier versions

Mar 2025 — Apr 2025 [monthly]

Recruiting PHASE1
Jan 2025 — Mar 2025 [monthly]

Recruiting PHASE1
Sep 2024 — Jan 2025 [monthly]

Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1
Jun 2024 — Jul 2024 [monthly]

Recruiting PHASE1
Apr 2024 — Jun 2024 [monthly]

Recruiting PHASE1
Nov 2023 — Apr 2024 [monthly]

Recruiting PHASE1
Oct 2023 — Nov 2023 [monthly]

Recruiting PHASE1
Feb 2023 — Oct 2023 [monthly]

Recruiting PHASE1
Jan 2023 — Feb 2023 [monthly]

Recruiting PHASE1
Nov 2022 — Jan 2023 [monthly]

Recruiting PHASE1
Jun 2022 — Nov 2022 [monthly]

Recruiting PHASE1
May 2022 — Jun 2022 [monthly]

Recruiting PHASE1
Apr 2022 — May 2022 [monthly]

Recruiting PHASE1
Mar 2022 — Apr 2022 [monthly]

Recruiting PHASE1
Jan 2022 — Mar 2022 [monthly]

Recruiting PHASE1
Dec 2021 — Jan 2022 [monthly]

Recruiting PHASE1
Oct 2021 — Dec 2021 [monthly]

Recruiting PHASE1
Sep 2021 — Oct 2021 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Jun 2021 — Sep 2021 [monthly]

Not Yet Recruiting PHASE1

First recorded

May 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SK Life Science, Inc.

Data source: SK Life Science, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bethesda, United States , Budapest, Hungary , Cheonju, South Korea , Cincinnati, United States , Columbia, United States , Durham, United States , Hackensack, United States , Memphis, United States , Phoenix, United States , Seoul, South Korea and 2 more locations